BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 15013649)

  • 1. Control of bladder function by peripheral nerves: avenues for novel drug targets.
    Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
    Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in detrusor muscle function.
    Fry CH; Hussain M; McCarthy C; Ikeda Y; Sui GP; Wu C
    Scand J Urol Nephrol Suppl; 2004; (215):20-5. PubMed ID: 15545193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative control of the lower urinary tract: preclinical perspective.
    de Groat WC
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S25-40. PubMed ID: 16465182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel in situ urinary bladder model for studying afferent and efferent mechanisms in the micturition reflex in the rat.
    Aronsson P; Carlsson T; Winder M; Tobin G
    Neurourol Urodyn; 2014 Jun; 33(5):550-7. PubMed ID: 23720131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
    Yoshida M; Miyamae K; Iwashita H; Otani M; Inadome A
    Urology; 2004 Mar; 63(3 Suppl 1):17-23. PubMed ID: 15013648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afferent mechanism in the urinary tract.
    Kanai AJ
    Handb Exp Pharmacol; 2011; (202):171-205. PubMed ID: 21290227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers.
    Lawrence GW; Aoki KR; Dolly JO
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1080-6. PubMed ID: 20576797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
    Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
    Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.
    Andersson KE; Persson K
    Scand J Urol Nephrol Suppl; 1995; 175():43-53. PubMed ID: 8771275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrusor myocyte activity and afferent signaling.
    Andersson KE
    Neurourol Urodyn; 2010; 29(1):97-106. PubMed ID: 20025035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of a capsaicin-sensitive innervation in the afferent branch of micturition reflex in rats.
    Maggi CA; Santicioli F; Meli A
    Acta Physiol Hung; 1987; 69(3-4):425-35. PubMed ID: 3477941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder activation: afferent mechanisms.
    Andersson KE
    Urology; 2002 May; 59(5 Suppl 1):43-50. PubMed ID: 12007522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of purinergic P2X receptor innervation in human detrusor and subepithelium from adults with sensory urgency.
    Ray FR; Moore KH; Hansen MA; Barden JA
    Cell Tissue Res; 2003 Dec; 314(3):351-9. PubMed ID: 14557870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of peripheral and central nicotinic receptors in the micturition reflex in rats.
    Masuda H; Hayashi Y; Chancellor MB; Kihara K; de Groat WC; de Miguel F; Yoshimura N
    J Urol; 2006 Jul; 176(1):374-9. PubMed ID: 16753446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury.
    de Groat WC; Yoshimura N
    Prog Brain Res; 2006; 152():59-84. PubMed ID: 16198694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic agonists and antagonists: effects on the urinary bladder.
    Sellers DJ; Chess-Williams R
    Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.
    Birder LA; Ruan HZ; Chopra B; Xiang Z; Barrick S; Buffington CA; Roppolo JR; Ford AP; de Groat WC; Burnstock G
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1084-91. PubMed ID: 15251862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats.
    Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.